FinTechFunding

Leukocare: Raises USD 17.5M in Financing

Leukocare Raises USD 17.5M in Financing

  • Leukocare AG, USA-based biotechnology company specialized in the field of biopharmaceutical formulation development, closed a USD 17.5m financing
  • The round was led by Petrichor Healthcare Capital Management, with participation from existing shareholders
  • The financing consists of a USD 15m convertible loan and a USD 2.5m equity investment from Petrichor
  • Proceeds will be used to accelerate company’s US expansion activities, bolster the company’s expertise in the fields of viral vector and vaccine formulation
  • The company is a biotechnology company specialized in the field of biopharmaceutical formulation development
  • In January 2021, The company started its US operations with the opening of development laboratories and offices in Milford, Massachusetts
Previous article
Edgeless Systems: Raises €1.45M in Seed Funding
Next article
Hive Pro: Raises $3M in Seed Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

DeFi Platform Drift Suspends Withdrawals After Crypto Hack

Drift takes precautionary measures following security breach affecting user funds.Highlights: Drift has suspended all deposits and withdrawals after...
FinTech

Cross River Bank Raises $50 Million to Accelerate Growth

The funding will enhance Cross River Bank's financial technology services.Highlights: Cross River Bank has raised $50 million in...
FinTech

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market.Highlights: Kulipa raises $62M to enhance its...
FinTech

Visa Launches AI-Powered Dispute Resolution Tools

New tools aim to streamline resolution of payment disputes.Highlights: Visa introduces AI tools for payment dispute resolution.The new...